Executive summary

P. Gay, R. Owens
{"title":"Executive summary","authors":"P. Gay, R. Owens","doi":"10.1787/145231cd-en","DOIUrl":null,"url":null,"abstract":"1808 Special Features The current national coverage determinations (NCDs) for noninvasive ventilation for patients with thoracic restrictive disorders, COPD, and hypoventilation syndromes were formulated in 1998. New original research, updated formal practice guidelines, and current consensus expert opinion have accrued that are in conflict with the existing NCDs. Some inconsistencies in the NCDs have been noted, and the diagnostic and therapeutic technology has also advanced in the last quarter century. Thus, these and related NCDs relevant to bilevel positive airway pressure for the treatment of OSA and central sleep apnea need to be updated to ensure the optimal health of patients with these disorders. To that end, the American College of Chest Physicians organized a multisociety (American Thoracic Society, American Academy of Sleep Medicine, and American Association for Respiratory Care) effort to engage experts in the field to: (1) identify current barriers to optimal care; (2) highlight compelling scientific evidence that would justify changes from current policies incorporating best evidence and practice; and (3) propose suggestions that would form the basis for a revised NCD in each of these 5 areas (thoracic restrictive disorders, COPD, hypoventilation syndromes, OSA, and central sleep apnea). The expert panel met during a 2-day virtual summit in October 2020 and subsequently crafted written documents designed to achieve provision of “the right device to the right patient at the right time.” These documents have been endorsed by the participating societies following peer review and publication in CHEST and will be used to inform efforts to revise the current NCDs. CHEST 2021; 160(5):1808-1821","PeriodicalId":433275,"journal":{"name":"Social Institutions and Gender Index","volume":"32 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Social Institutions and Gender Index","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1787/145231cd-en","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

1808 Special Features The current national coverage determinations (NCDs) for noninvasive ventilation for patients with thoracic restrictive disorders, COPD, and hypoventilation syndromes were formulated in 1998. New original research, updated formal practice guidelines, and current consensus expert opinion have accrued that are in conflict with the existing NCDs. Some inconsistencies in the NCDs have been noted, and the diagnostic and therapeutic technology has also advanced in the last quarter century. Thus, these and related NCDs relevant to bilevel positive airway pressure for the treatment of OSA and central sleep apnea need to be updated to ensure the optimal health of patients with these disorders. To that end, the American College of Chest Physicians organized a multisociety (American Thoracic Society, American Academy of Sleep Medicine, and American Association for Respiratory Care) effort to engage experts in the field to: (1) identify current barriers to optimal care; (2) highlight compelling scientific evidence that would justify changes from current policies incorporating best evidence and practice; and (3) propose suggestions that would form the basis for a revised NCD in each of these 5 areas (thoracic restrictive disorders, COPD, hypoventilation syndromes, OSA, and central sleep apnea). The expert panel met during a 2-day virtual summit in October 2020 and subsequently crafted written documents designed to achieve provision of “the right device to the right patient at the right time.” These documents have been endorsed by the participating societies following peer review and publication in CHEST and will be used to inform efforts to revise the current NCDs. CHEST 2021; 160(5):1808-1821
执行概要
目前针对胸限制性疾病、慢性阻塞性肺病和低通气综合征患者无创通气的全国覆盖率测定(NCDs)是在1998年制定的。新的原始研究、更新的正式实践指南和目前的共识专家意见已经产生,这些都与现有的非传染性疾病相冲突。人们注意到非传染性疾病的一些不一致之处,在过去的25年里,诊断和治疗技术也取得了进步。因此,这些以及与双水平气道正压治疗阻塞性睡眠呼吸暂停和中枢睡眠呼吸暂停相关的非传染性疾病需要更新,以确保这些疾病患者的最佳健康状况。为此,美国胸科医师学会组织了一个多协会(美国胸科学会、美国睡眠医学学会和美国呼吸护理协会),努力吸引该领域的专家:(1)确定目前实现最佳护理的障碍;(2)强调令人信服的科学证据,证明当前政策的改变是合理的,并结合最佳证据和实践;(3)对这5个领域(胸腔限制性疾病、慢性阻塞性肺病、低通气综合征、阻塞性睡眠呼吸暂停和中央性睡眠呼吸暂停)的NCD修订提出建议。专家小组在2020年10月举行了为期两天的虚拟峰会,随后起草了书面文件,旨在实现“在正确的时间向正确的患者提供正确的设备”。这些文件经同行评议并在《CHEST》上发表后得到了参与协会的认可,并将用于为修订当前非传染性疾病的工作提供信息。胸部2021;160 (5): 1808 - 1821
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信